Share
- Release Date: 30/10/12 15:37
- Summary: DIRECTOR: FPH: APPOINTMENT OF NEW DIRECTOR
- Price Sensitive: No
- Download Document 2.65KB
FPH
30/10/2012 13:37
DIRECTOR
REL: 1337 HRS Fisher & Paykel Healthcare Corporation Limited
DIRECTOR: FPH: APPOINTMENT OF NEW DIRECTOR
APPOINTMENT OF NEW DIRECTOR
Auckland, New Zealand, 30 October 2012 - Fisher & Paykel Healthcare
Corporation Limited (NZSX:FPH, ASX:FPH) advise that Donal O'Dwyer has been
appointed as an additional non-executive director of the company effective 1
December 2012.
"As part of the Board's ongoing refreshment process and following the
indication from Gary Paykel and Nigel Evans that they plan to retire from the
Board following the ASM next year, Donal is the first of the two new director
appointments we will be making and will help to ensure a smooth transition
when Gary and Nigel retire" said Chairman Tony Carter.
The company will next year commence the search for a second new director to
join the Board.
"With over 20 years' experience as a senior executive in the global
cardiovascular and medical device industries, Donal is extremely well
qualified to contribute to Fisher & Paykel Healthcare's board at a time when
we are continuing to expand our international presence."
"Donal combines extensive governance experience with a strong entrepreneurial
record from his time at Cordis Cardiology and Baxter Healthcare" said Mr
Carter.
From 1996 to 2003, Mr O'Dwyer worked for Cordis Cardiology, the cardiology
division of Johnson & Johnson's Cordis Corporation, initially as its
president (Europe) and from 2000 to 2003 as its worldwide president. Prior to
joining Cordis, Mr O'Dwyer worked for 12 years with Baxter Healthcare, rising
from plant manager in Ireland to president of the Cardiovascular Group,
Europe, now Edwards Lifesciences.
Mr O'Dwyer is currently Chairman of Atcor Medical Pty Limited as well as
being a non-executive director of Cochlear Limited, Sunshine Heart Inc and
Mesoblast Limited. Mr O'Dwyer is resident in Australia, is a qualified civil
engineer and has an MBA.
The Fisher & Paykel Healthcare board has determined that Mr O'Dwyer will be
an independent director.
"Donal will undoubtedly bring great insights and experience to our board, and
we look forward to working alongside him to deliver growth in value to our
shareholders" Tony Carter said.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer
of products and systems for use in respiratory care, acute care and the
treatment of obstructive sleep apnea. The company's products are sold in
over 120 countries worldwide. For more information about the company visit
www.fphcare.com
Contact: Tony Barclay, Company Secretary on +64 9 574 0119.
End CA:00229060 For:FPH Type:DIRECTOR Time:2012-10-30 13:37:24
